Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gayathri Ravi

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Blood|January 27, 2026
Distinct trajectory of measurable residual disease in t(11;14) myeloma treated with quadruplet therapySusan Bal, Gayathri Ravi, Binod Dhakal, et al.
Journal of Geriatric Oncology|September 6, 2024
Evaluating concordance between International Myeloma Working Group (IMWG) frailty score and simplified frailty scale among older adults with multiple myelomaAndrew Gahagan, Supriya Maheshwari, Sunil Rangarajan, et al.
Bone Marrow Transplantation|September 18, 2020
History of drug use in allogeneic hematopoietic cell transplant recipientsMouhamed Yazan Abou-Ismail, Gayathri Ravi, Pingfu Fu, et al.
British Journal of Haematology|February 16, 2026
Validation of the 2025 IMS/IMWG risk classification in patients with newly diagnosed multiple myeloma treated with quadruplets and autologous stem cell transplantPriyanka Venkatesh, Gayathri Ravi, Binod Dhakal, et al.
British Journal of Cancer|June 7, 2024
Anthropometric traits and risk of multiple myeloma: differences by race, sex and diagnostic clinical featuresKevin D Arnold, Krystle L Ong, Gayathri Ravi, et al.
Transplantation and Cellular Therapy|April 8, 2021
Physical Activity and Sleep Measures Using a Fitness Tracking Device during Hematopoietic Cell Transplantation: A Pilot StudyNajla El Jurdi, Nora Nock, Pingfu Fu, et al.
Leukemia|February 5, 2025
Phase 1 clinical trial of B-Cell Maturation Antigen (BCMA) NEX-T® Chimeric Antigen Receptor (CAR) T cell therapy CC-98633/BMS-986354 in participants with triple-class exposed multiple myelomaGayathri Ravi, Shambavi Richard, Shaji Kumar, et al.
British Journal of Haematology|March 14, 2022
Does recipient body mass index inform donor selection for allogeneic haematopoietic cell transplantation?Mouhamed Yazan Abou-Ismail, Raphael Fraser, Mariam Allbee-Johnson, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Blood|January 27, 2026
Distinct trajectory of measurable residual disease in t(11;14) myeloma treated with quadruplet therapySusan Bal, Gayathri Ravi, Binod Dhakal, et al.
Journal of Geriatric Oncology|September 6, 2024
Evaluating concordance between International Myeloma Working Group (IMWG) frailty score and simplified frailty scale among older adults with multiple myelomaAndrew Gahagan, Supriya Maheshwari, Sunil Rangarajan, et al.
Bone Marrow Transplantation|September 18, 2020
History of drug use in allogeneic hematopoietic cell transplant recipientsMouhamed Yazan Abou-Ismail, Gayathri Ravi, Pingfu Fu, et al.
British Journal of Haematology|February 16, 2026
Validation of the 2025 IMS/IMWG risk classification in patients with newly diagnosed multiple myeloma treated with quadruplets and autologous stem cell transplantPriyanka Venkatesh, Gayathri Ravi, Binod Dhakal, et al.
British Journal of Cancer|June 7, 2024
Anthropometric traits and risk of multiple myeloma: differences by race, sex and diagnostic clinical featuresKevin D Arnold, Krystle L Ong, Gayathri Ravi, et al.
Transplantation and Cellular Therapy|April 8, 2021
Physical Activity and Sleep Measures Using a Fitness Tracking Device during Hematopoietic Cell Transplantation: A Pilot StudyNajla El Jurdi, Nora Nock, Pingfu Fu, et al.
Leukemia|February 5, 2025
Phase 1 clinical trial of B-Cell Maturation Antigen (BCMA) NEX-T® Chimeric Antigen Receptor (CAR) T cell therapy CC-98633/BMS-986354 in participants with triple-class exposed multiple myelomaGayathri Ravi, Shambavi Richard, Shaji Kumar, et al.
British Journal of Haematology|March 14, 2022
Does recipient body mass index inform donor selection for allogeneic haematopoietic cell transplantation?Mouhamed Yazan Abou-Ismail, Raphael Fraser, Mariam Allbee-Johnson, et al.
Pageof 2